Bloodstream infections, also known as bacteremia or septicemia, occur when bacteria or other pathogens enter the bloodstream, leading to a systemic infection. These infections can arise from various sources, such as untreated wounds, surgical procedures, urinary tract infections, or infections in other parts of the body. Symptoms of bloodstream infections may include fever, chills, rapid heartbeat, low blood pressure, and general malaise. Severe cases can progress to sepsis, a life-threatening condition that can lead to organ failure. Diagnosis typically involves blood cultures, which identify the specific pathogen causing the infection. Early detection and appropriate treatment with antibiotics are crucial to preventing the spread of the infection and minimizing complications. Risk factors for bloodstream infections include weakened immune systems, chronic illnesses, invasive medical procedures, and the presence of medical devices like catheters. Preventive measures include proper hygiene, infection control practices in healthcare settings, and prompt treatment of infections at their source. Bloodstream infections pose a significant health threat, requiring prompt medical attention and intervention to ensure optimal outcomes for affected individuals.
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Prophylactic and Molecular Approaches for Mitigating Human Influenza A Viruses: i. Evaluating influenza Vaccine Effectiveness in the Older population ii. Down-regulation of influenza virus genes with novel siRNA-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a Novel Multi-component Vaccine to Address the Burden of Otitis Media in High-Risk Populations
Ayesha Zahid, Griffith University, Australia
Title : Targeting resistance: New 4-substituted pyrazolidine and isoxazolidine as antibiotics with interesting antimicrobial activities
Yousfi Tarek, Nationale Research for Biotechnology Research Center, Algeria
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Immunosuppression in COVID-19 Patients and Emerging Fungal Infections: Vaccines, Diagnosis and Strategies to Treat Comorbidities
K R Aneja, Kurukshetra University, India
Title : Immunogenicity and Cryo-EM structure of native-like HIV-1 Clade-C envelope trimers derived from a pediatric elite-neutralizer
Swarandeep Singh, All India Institute of Medical Sciences, India
Title : Why is the vaccine life-threatening if people get a fever after a COVID-19 vaccination
Yacob Mathai, Marma Health Centre, India
Title : Barriers to polio eradication in South Asia: A systematic review
Awranoos Ahadi, Bolan Medical College, Pakistan